{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:00:22Z","timestamp":1783980022745,"version":"3.55.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>Microscopic examination of acid-fast-stained sputum smears is the current standard of care in the United States to determine airborne infection isolation (AII) of inpatients with presumptive pulmonary tuberculosis (PTB). However, nucleic acid amplification testing (NAAT) with the Xpert MTB\/RIF assay (Xpert) may be more efficient and less costly.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>This prospective observational cohort study enrolled a consecutive sample of 318 AII-eligible inpatients from a public hospital in Seattle, Washington, from March 2012 to October 2013. Sputum samples were collected from each inpatient and analyzed using smear microscopy, culture, drug susceptibility testing, and NAAT. The performance, clinical utility (AII duration and survival), and cost-effectiveness from an institutional perspective were compared for 5 testing strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Among the 318 admissions with presumptive PTB, 20 (6.3%) were culture-positive for Mycobacterium tuberculosis. The sensitivity of 1 Xpert, 2 Xperts, 2 smears, or 3 smears compared to culture was 0.85 (95% confidence interval [CI], .61\u2013.96), 0.95 (95% CI, .73\u20131.0), 0.70 (95% CI, .46\u2013.88), and 0.80 (95% CI, .56\u2013.93), respectively. A cost-effectiveness analysis of the study results demonstrated that an Xpert test on 1 unconcentrated sputum sample (assuming equivalent results for unconcentrated and concentrated sputum samples) is the most cost-effective strategy (99.9% preferred at willingness-to-pay of US$50000) and on average would save 51.5 patient-hours in AII and up to $11466 relative to microscopy without a compromise in sensitivity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>In hospitalized patients with presumptive PTB in a low-burden setting, NAAT can reduce AII and is comparably sensitive, more specific, and more cost-effective than smear microscopy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciw803","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T04:31:29Z","timestamp":1480480289000},"page":"482-489","source":"Crossref","is-referenced-by-count":32,"title":["Clinical Impact and Cost-effectiveness of Xpert MTB\/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States"],"prefix":"10.1093","volume":"64","author":[{"given":"James F.","family":"Cowan","sequence":"first","affiliation":[{"name":"Department of Global Health, University of Washington Schools of Medicine and Public Health 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldine S.","family":"Chandler","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kracen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine 2"},{"name":"Harborview Medical Center 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn K.","family":"Wallis","sequence":"additional","affiliation":[{"name":"Harborview Medical Center 3"},{"name":"Department of Laboratory Medicine, University of Washington School of Medicine 4 , Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelline","family":"Liu","sequence":"additional","affiliation":[{"name":"Cepheid 5 , Sunnyvale, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[{"name":"Cepheid 5 , Sunnyvale, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Persing","sequence":"additional","affiliation":[{"name":"Cepheid 5 , Sunnyvale, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferric C.","family":"Fang","sequence":"additional","affiliation":[{"name":"Harborview Medical Center 3"},{"name":"Department of Laboratory Medicine, University of Washington School of Medicine 4 , Seattle"},{"name":"Department of Microbiology, University of Washington School of Medicine 6 , Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"2024111411402557500_CIT0001","first-page":"1","article-title":"A strategic plan for the elimination of tuberculosis in the United States","volume":"38","author":"Dowdle","year":"1989","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024111411402557500_CIT0002","first-page":"265","article-title":"Tuberculosis trends\u2013United States, 2014","volume":"64","author":"Scott","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"2024111411402557500_CIT0003","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"2024111411402557500_CIT0004","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","article-title":"Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes","volume":"369","author":"Getahun","year":"2007","journal-title":"Lancet"},{"key":"2024111411402557500_CIT0005","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.5588\/ijtld.13.0095","article-title":"Cost-effectiveness of Xpert MTB\/RIF for diagnosing pulmonary tuberculosis in the United States","volume":"17","author":"Choi","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024111411402557500_CIT0006","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1183\/13993003.01333-2015","article-title":"Cost-benefit analysis of Xpert MTB\/RIF for tuberculosis suspects in German hospitals","volume":"47","author":"Diel","year":"2016","journal-title":"Eur Respir J"},{"key":"2024111411402557500_CIT0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.rmed.2011.10.005","article-title":"The cost effectiveness of nucleic acid amplification techniques for the diagnosis of tuberculosis","volume":"106","author":"Hughes","year":"2012","journal-title":"Respir Med"},{"key":"2024111411402557500_CIT0008","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciu626","article-title":"Editorial commentary: Xpert MTB\/RIF testing for individuals with presumed tuberculosis: implications for infection control and rapid tuberculosis detection in the united states","volume":"59","author":"Shah","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411402557500_CIT0009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"2024111411402557500_CIT0010","first-page":"CD009593","article-title":"Xpert MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults","volume":"1","author":"Steingart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2024111411402557500_CIT0011","volume-title":"Tuberculosis diagnostics: Xpert MTB\/RIF test","author":"World Health Organization"},{"key":"2024111411402557500_CIT0012","doi-asserted-by":"crossref","first-page":"e110558","DOI":"10.1371\/journal.pone.0110558","article-title":"Modeling of novel diagnostic strategies for active tuberculosis\u2014a systematic review: current practices and recommendations","volume":"9","author":"Zwerling","year":"2014","journal-title":"PLoS One"},{"key":"2024111411402557500_CIT0013","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2214-109X(14)70370-5","article-title":"Cost-effectiveness of Xpert MTB\/RIF and investing in health care in Africa","volume":"3","author":"Langley","year":"2015","journal-title":"Lancet Glob Health"},{"key":"2024111411402557500_CIT0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(13)70008-2","article-title":"Advances in tuberculosis diagnostics: the Xpert MTB\/RIF assay and future prospects for a point-of-care test","volume":"13","author":"Lawn","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2024111411402557500_CIT0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-14-2","article-title":"Results from early programmatic implementation of Xpert MTB\/RIF testing in nine countries","volume":"14","author":"Creswell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2024111411402557500_CIT0016","first-page":"125","article-title":"Implementing rapid testing for tuberculosis in Mozambique","volume-title":"Bull World Health Organ","author":"Cowan","year":"2015"},{"key":"2024111411402557500_CIT0017","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1164\/rccm.200803-381OC","article-title":"Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test","volume":"178","author":"Campos","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2024111411402557500_CIT0018","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciu620","article-title":"Impact of GeneXpert MTB\/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial","volume":"59","author":"Chaisson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411402557500_CIT0019","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1164\/rccm.201311-1974OC","article-title":"Impact of GeneXpert MTB\/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial","volume":"189","author":"Davis","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2024111411402557500_CIT0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/cid\/cit336","article-title":"The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States","volume":"57","author":"Marks","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024111411402557500_CIT0021","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(98)03406-0","article-title":"Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli","volume":"353","author":"Behr","year":"1999","journal-title":"Lancet"},{"key":"2024111411402557500_CIT0022","first-page":"485","article-title":"Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review","volume":"11","author":"Mase","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024111411402557500_CIT0023","first-page":"3482","article-title":"Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation?","volume":"40","author":"Mathew","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2024111411402557500_CIT0024","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1155\/2011\/314686","article-title":"The role of the third acid-fast bacillus smear in tuberculosis screening for infection control purposes: a controversial topic revisited","volume":"22","author":"Wilmer","year":"2011","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2024111411402557500_CIT0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhin.2010.04.027","article-title":"Adverse effects of isolation in hospitalised patients: a systematic review","volume":"76","author":"Abad","year":"2010","journal-title":"J Hosp Infect"},{"key":"2024111411402557500_CIT0026","first-page":"i","article-title":"FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin","volume-title":"US Food and Drug Administration","year":"2013"},{"key":"2024111411402557500_CIT0027","volume-title":"US Food and Drug Administration. New data shows test can help physicians remove patients with suspected TB from isolation earlier","year":"2015"},{"key":"2024111411402557500_CIT0028","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10096-012-1798-0","article-title":"Performance of Cepheid Xpert MTB\/RIF and TB-Biochip MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis","volume":"32","author":"Kurbatova","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024111411402557500_CIT0029","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2024111411402557500_CIT0030","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/cid\/ciu022","article-title":"Xpert MTB\/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact","volume":"58","author":"Sohn","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411402557500_CIT0031","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/cid\/ciu212","article-title":"Xpert MTB\/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States","volume":"59","author":"Lippincott","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411402557500_CIT0032","volume-title":"Diagnostics for tuberculosis: global demand and market potential","author":"Foundation for Innovative New Diagnostics (FIND)","year":"2006"},{"key":"2024111411402557500_CIT0033","doi-asserted-by":"crossref","first-page":"e79669","DOI":"10.1371\/journal.pone.0079669","article-title":"Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis","volume":"8","author":"Millman","year":"2013","journal-title":"PLoS One"},{"key":"2024111411402557500_CIT0034","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JCM.02214-10","article-title":"Evaluation of the Cepheid Xpert MTB\/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens","volume":"49","author":"Marlowe","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2024111411402557500_CIT0035","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.290.14.1899","article-title":"Safety of patients isolated for infection control","volume":"290","author":"Stelfox","year":"2003","journal-title":"JAMA"},{"key":"2024111411402557500_CIT0036","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/665314","article-title":"Impact of isolation on hospital consumer assessment of healthcare providers and systems scores: is isolation isolating?","volume":"33","author":"Vinski","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024111411402557500_CIT0037","doi-asserted-by":"crossref","first-page":"e100649","DOI":"10.1371\/journal.pone.0100649","article-title":"Cost analysis of a nucleic acid amplification test in the diagnosis of pulmonary tuberculosis at an urban hospital with a high prevalence of TB\/HIV","volume":"9","author":"Adelman","year":"2014","journal-title":"PLoS One"},{"key":"2024111411402557500_CIT0038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4269\/ajtmh.2012.12-0107","article-title":"Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB\/RIF?","volume":"87","author":"Kirwan","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"2024111411402557500_CIT0039","first-page":"193","article-title":"Revised device labeling for the Cepheid Xpert MTB\/RIF assay for detecting Mycobacterium tuberculosis","volume":"64","year":"2015","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/4\/482\/13804025\/ciw803.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/4\/482\/13804025\/ciw803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:52:46Z","timestamp":1731585166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/4\/482\/2666525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,12,10]]},"published-print":{"date-parts":[[2017,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw803","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,15]]},"published":{"date-parts":[[2016,12,10]]}}}